Mouse Anti-GRM1 Recombinant Antibody (CBFYM-0412) (CBMAB-M0520-FY)

Sun, S., Kong, Q., Cai, Z., Wang, M., Zhao, H., & Zhao, C. (2021). circ‑Grm1 promotes pulmonary artery smooth muscle cell proliferation and migration via suppression of GRM1 expression by FUS. International Journal of Molecular Medicine, 48(5), 1-12.

Shah, R., Singh, S. J., Eddy, K., Filipp, F. V., & Chen, S. (2019). Concurrent targeting of glutaminolysis and metabotropic glutamate receptor 1 (GRM1) reduces glutamate bioavailability in GRM1+ melanoma. Cancer research, 79(8), 1799-1809.

Shah, R., Singh, S., Eddy, K., Filipp, F., & Chen, S. (2019). Concurrent inhibition of glutaminase (GLS) and metabotropic receptor 1 (GRM1) reduced glutamate bioavailability and led to a decrease in GRM1-expressing melanoma cell proliferation in vitro and tumor progression in vivo. Cancer Research, 79(13_Supplement), 1839-1839.

Isola, A. L., Eddy, K., Zembrzuski, K., Goydos, J. S., & Chen, S. (2018). Exosomes released by metabotropic glutamate receptor 1 (GRM1) expressing melanoma cells increase cell migration and invasiveness. Oncotarget, 9(1), 1187.

Dalley, C. B., Wroblewska, B., Wolfe, B. B., & Wroblewski, J. T. (2018). The role of metabotropic glutamate receptor 1 dependent signaling in glioma viability. Journal of Pharmacology and Experimental Therapeutics, 367(1), 59-70.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols